Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $27.3M in Market Capitalization this March of 2025, considering the latest stock price and the number of outstanding shares.Data for Acasti Pharma | ACST - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported 32 in Employees for its fiscal year ending in March of 2021. Data for Acasti Pharma | ACST - Employees Total Number including historical, tables and charts were last updated by Trading Economics this last February in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-0.36 in Selling and Administration Expenses for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Selling And Administration Expenses including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $52.14M in Equity Capital and Reserves for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Equity Capital And Reserves including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $0 in Loan Capital for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Loan Capital including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-3704000 in EBIT for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Ebit including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported 9.94 in PE Price to Earnings for its fiscal quarter ending in March of 2021. Data for Acasti Pharma | ACST - PE Price to Earnings including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-0.36 in Trade Creditors for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Trade Creditors including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $11.94M in Current Assets for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Current Assets including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $1000 in Ordinary Share Capital for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Ordinary Share Capital including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $0 in Debt for its fiscal quarter ending in September of 2024. Data for Acasti Pharma | ACST - Debt including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-4829000 in EBITDA for its fiscal quarter ending in September of 2024. Data for Acasti Pharma | ACST - Ebitda including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma reported $-4155000 in Net Income for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Net Income including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma 미결제 주식 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2025.Data for Acasti Pharma | 미결제 주식 including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Acasti Pharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.